Summary of findings table ‐ Subcutaneous biologics (dupilumab) vs placebo
Short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of · adults with alopecia areata
Summary of findings table ‐ Subcutaneous biologics (dupilumab) showed no clear difference in short‐term hair regrowth ≥ 75% compared with placebo (low certainty).
1 finding from 1 review
- RR 3.59 [0.19, 66.22]1 study · 60 participantsLow